期刊文献+

粒-巨噬细胞集落刺激因子在流产患者血清中的浓度及在子宫蜕膜组织中的表达研究 被引量:5

The serum concentration of granulocyte-macrophage colony-stimulating factor in abortion patients and its expression in decidual tissue
下载PDF
导出
摘要 目的测定粒-巨噬细胞集落刺激因子(GM-CSF)在流产患者血清中的浓度及在子宫蜕膜组织中的表达量,探讨其意义并分析可能的影响因素。方法前瞻性留取2012年5月至2014年10月间就诊的先兆流产、难免流产患者与同期正常妊娠妇女外周血及子宫蜕膜组织,采用酶联免疫吸附试验(ELISA)分别测定先兆流产(58例)、难免流产(40例)、正常妊娠妇女(50例)血清GM-CSF浓度,并采用实时PCR技术分别检测难免流产(16例)、正常妊娠者(23例)子宫蜕膜组织中GM-CSF mRNA的表达量。运用统计学方法比较各组间GM-CSF水平差异,分析血清GMCSF浓度与蜕膜GM-CSF mRNA的表达量的相关性,并探讨GM-CSF水平与患者年龄、孕龄、血清β人绒毛膜促性腺激素(β-h CG)水平及孕酮水平的关系。结果先兆流产组与正常妊娠组血清GM-CSF浓度分别为(497.8±25.4)pg/ml、(543.1±29.3)pg/ml,均显著高于难免流产组血清GM-CSF水平(186.7±16.8)pg/ml(P<0.05)。难免流产组子宫蜕膜组织中GM-CSF mRNA的表达相对值(1.952±0.166)显著低于正常妊娠组(3.203±0.257)(P<0.05)。难免流产组和正常妊娠组的血清与蜕膜组织中GM-CSF水平均呈高度正相关(r=0.921、0.854,P<0.05)。三组患者的血清GM-CSF水平均与其年龄因素无关,而与孕龄呈中度正相关(r=0.723、0.573、0.509,P<0.05),与血清β-h CG水平(r=0.417、0.381、0.453,P<0.05)及孕酮水平(r=0.359、0.302、0.467,P<0.05)低度正相关。结论(1)难免流产患者血清GM-CSF水平显著低于正常妊娠妇女,提示GM-CSF在妊娠维持中可能起保护作用,GM-CSF水平降低至一定水平将导致流产发生。(2)GM-CSF在先兆流产和难免流产患者体内水平有显著性差异,提示测定流产患者体内GM-CSF水平对于判断预后具有一定意义。(3)妊娠时的血清和蜕膜组织中的GM-CSF水平具有高度相关性,反映了血清GM-CSF主要来源于蜕膜组织。(4)GM-CSF在妊娠维持中的作用可能与h CG和孕酮作用有关。 Objective To determine the serum concentration of granulocyte-macrophage colony-stimulating factor(GM-CSF)in patients with spontaneous abortion and its expression in decidual tissue,and to analysis its affecting factors.Methods Patients with threatened abortion,inevitable abortion and normal pregnancy from May2012to October2014diagnosed in Affiliated Hospital of North Sichuan Medical College were enrolled in our study.Serum granulocyte-macrophage colony-stimulating factor concentration by using enzyme-linked immunosorbent assay(ELISA)were measured in58threatened abortions,in40inevitable abortions and in50normal pregnancies.Expressions of GM-CSF mRNA in decidual tissues were detected using real time PCR(real-time PCR)in16inevitable abortions and in23normal pregnancies.GM-CSF level differences between groups were compared,correlation analysis between the expression of serum concentration of GM-CSF and GM-CSF mRNA in decidual cells mRNA were determined,and to explore the association between age of patients,gestational age,beta-hCG level serum,progesterone level and serum GM-CSF level.Results The concentration of serum GM-CSF in threatened abortion group and in normal pregnancy group were497.8±25.4pg/ml,and543.1±29.3pg/ml,respectively,which were significantly higher than that in inevitable abortion group(186.7±16.8pg/ml)(P<0.05).The expression relative values in decidual tissues of GM-CSF mRNA in patients with inevitable abortions were1.952±0.166,significantly lower than that in normal pregnancy group(3.203±0.257)(P<0.05).The serum GM-CSF levels in inevitable abortion group and normal pregnancy group in decidual tissues showed highly positive correlation(r=0.921,0.854,P<0.05).The serum GM-CSF levels in all three groups were associated with gestational age(r=0.723,0.573,0.509,P<0.05),with serum beta-human chorionic gonadotropin(beta-HCG)levels(r=0.417,0.381,0.453,P<0.05)and with progesterone(r=0.359,0.302,0.467,P<0.05).Conclusion Serum GM-CSF levels in patients with inevitable abortions were significantly lower than those in normal pregnant women,suggesting that serum GM-CSF may play a protective role in pregnancy maintenance,reduce to a certain level will lead to abortion.There was a significant difference in threatened abortion and inevitable abortion in patients with GM-CSF levels,suggesting that serum GM-CSF level may have a prediction role in prognosis of abortion.Serum GM-CSF may mainly come from decidua because of association between serum and decidual tissue.GM-CSF may be associated with hCG and progesterone in maintenance of pregnancy.
作者 范波 黄晓萍 邵建兰 FAN Bo;HUANG Xiao-ping;SHAO Jian-lan(Department of Obstetrics and Gynecology, Affiliated Hospital of North Sichuan Medical College, Nanchong Sichuan 637000, China)
出处 《临床和实验医学杂志》 2018年第5期466-471,共6页 Journal of Clinical and Experimental Medicine
关键词 流产 粒-巨噬细胞集落刺激因子 子宫蜕膜 Abortion Granulocyte-macrophage colony-stimulating factor Decidua
  • 相关文献

参考文献4

二级参考文献58

  • 1邱丽华,林其德.调节性T淋巴细胞与原因不明复发性流产的相关性研究[J].中华妇产科杂志,2004,39(12):816-818. 被引量:49
  • 2洪燕,林其德,汪希鹏.蜕膜杀伤细胞免疫球蛋白样受体谱表达与原因不明性流产的关系[J].现代妇产科进展,2005,14(3):214-217. 被引量:7
  • 3Metcalf D. The molecular biology and functions of the ranulocyte- macrophage colony-stimulating factors. Blood, 1986, 67:257-267.
  • 4Schuurman B, Heuff G, Beelen RH, et al. Enhanced killing ca- pacity of human Kupffer cells after activation with human granulo- cyte/macrophage-colony-stimulating factor and interferon-γ. Canc- er lmmunol Immunother, 1994, 39 : 179-184.
  • 5Oosterling S J, Mels AK, Geijtenbeek TB, et al. Preoperative gran- ulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients. Immunobiology, 2006, 211:641-649.
  • 6Cartron G, Zhao-Yang L, Baudard M, et al. Granulocyte-macro- phage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase lI study. J Clin Oncol, 2008, 26:2725-2731.
  • 7Karmali R, Larson ML, Wooldridge JE, et al. Granulocyte-macro- phage colony stimulating factor-induced immune priming of cyclo- phosphamide, doxorubicin, vincristine, and prednisone with ritux- imab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell lymphoma. Leuk Lymphoma, 2011,52 : 2097-2104.
  • 8Chang JE, Seo S, Kim KM, et al. Rituximab and CHOP chemo- therapy plus GM-CSF for previously untreated diffuse large B-cell lymphoma in the elderly: a Wisconsin oneology network study. Clin Lymphoma Myeloma Leuk, 2010, 10:379-384.
  • 9Font A, Moyano AJ, Puerto JM, et al. Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma: a phase III randomized trial of the Spanish Lung Cancer Group. Cancer, 1999, 85:855-63.
  • 10Correale P, Miano ST, Remondo C, et al. Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetax- el + / - granulocyte-macrophage colony stimulating factor and low dose aldesleukine. Cancer Biol Ther, 2009, 8 : 497-502.

共引文献77

同被引文献56

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部